Why is Prism Medico falling/rising?

As of 15-Sep, Prism Medico & Pharmacy Ltd is experiencing a decline in its stock price, currently at 17.11, which reflects a decrease of 0.2 or 1.16%. The stock has underperformed its sector today by 0.98% and has fallen after two consecutive days of gains. In terms of returns, the stock has seen a 1-week decline of 2.89% and a year-to-date drop of 29.30%, while it has performed positively over the last month with a 28.74% increase. Despite some positive quarterly results, including the highest PBDIT and PAT figures, the company faces challenges such as weak long-term fundamental strength and a negative CAGR growth in operating profits over the last five years, which may contribute to investor concerns. Broader market context indicates that while the Sensex has gained 1.24% over the past week, Prism Medico's performance has lagged significantly, particularly with a year-over-year return of -49.02% compared to the market's slight decline of -1.33%. This stark contrast highlights the company's struggles relative to broader market trends. Additionally, the company's weak ability to service its debt and low profitability per unit of shareholder funds further exacerbate the negative sentiment surrounding the stock, leading to its current price decline.